LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-17
Case ID: NM_006005.3_c.2327A_T_20261117_234725
Framework: ACMG/AMP 2015
Variant classification summary

NM_006005.3:c.2327A>T

WFS1  · NP_005996.2:p.(Glu776Val)  · NM_006005.3
GRCh37: chr4:6303849 A>T  ·  GRCh38: chr4:6302122 A>T
Gene: WFS1 Transcript: NM_006005.3
Final call
VUS
PP3 strong BS4 strong
All criteria require review: For research and educational purposes only.
Gene
WFS1
Transcript
NM_006005.3
Protein
NP_005996.2:p.(Glu776Val)
gnomAD AF
0.004237645419127001 (v4.1)
ClinVar
Likely benign
OncoKB
Interpretation summary
Generated evidence synthesis
1
PP3 strong: REVEL 0.981 exceeds the generic missense threshold of 0.932.
2
BS4 strong: p.Glu776Val did not segregate with hearing impairment in the studied families.
Final determination: Under the generic ACMG/AMP 2015 fallback, one strong pathogenic criterion and one strong benign criterion meet neither a pathogenic nor a benign combination rule, yielding VUS.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PS1 Not met Not met: WFS1 p.Glu776Val is reported as benign or likely benign, with no previously established pathogenic variant producing the same amino-acid change.
clinvar PMID:34997062
PS2 Not met Not met: the variant was maternally inherited, not observed as de novo with confirmed maternity and paternity.
PMID:34997062
PS3 Not assessed Not assessed: no variant-specific validated functional assay showing a damaging effect was identified for WFS1 p.Glu776Val.
PMID:26435059 PMID:34997062
PS4 Not assessed Not assessed: no case-control counts or odds ratio with a 95% confidence interval were available to test the PS4 >5.0 and CI-excludes-1.0 requirement.
PMID:20301607 PMID:20301750 PMID:24909696 PMID:34997062
PM1 Not met Not met: residue 776 has no documented critical functional domain or qualifying hotspot, and the available C-terminal regional observation is not a defined PM1 domain.
hotspots cosmic PMID:26435059
PM2 Not met Not met: the variant's all-comers gnomAD AF is 0.004237645419127001, exceeding the PM2 threshold of 0.0001.
gnomad_v2 gnomad_v4 PMID:25741868
PM3 Not assessed Not assessed: maternal inheritance is reported, but no affected proband has a documented pathogenic WFS1 allele in trans with phase established.
PMID:34997062 PMID:24909696
PM4 N/A Not applicable: PM4 requires a protein-length change, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PM5 Not met Not met: the only same-residue comparator, E776K, is computationally predicted damaging but not established pathogenic.
PMID:37185285 clinvar
PM6 Not met Not met: maternal inheritance was reported, so the evidence does not support an assumed de novo occurrence without parental confirmation.
PMID:34997062
PP1 Not met Not met: p.Glu776Val did not segregate with hearing impairment in the studied families, so co-segregation is not demonstrated.
PMID:24909696 PMID:34997062
PP2 Not met Not met: WFS1 p.Glu776Val has gnomAD v4.1 allele frequency 0.00423765 and benign ClinVar submissions, arguing against a low benign-missense rate.
gnomad_v4 clinvar PMID:28432734
PP3 Met Met, strong: missense REVEL score 0.981 exceeds the generic PP3 strong threshold of 0.932.
revel
PP4 Not assessed Not assessed: the case lacks a sufficiently specific patient phenotype or family history establishing a single genetic etiology for PP4.
PMID:24909696 PMID:34997062
PP5 Not met Not met: ClinVar has 0 expert-panel submissions for the exact variant, and no reviewed source reports it as pathogenic under PP5.
clinvar PMID:34997062
BA1 Not met Not met: gnomAD grpmax FAF is 0.00511863 at most, below the 0.05 BA1 threshold despite a higher Finnish popmax point estimate.
gnomad_v2 gnomad_v4 PMID:25741868
BS1 Not met Not met: the qualifying gnomAD grpmax FAF is 0.00511863, below the generic BS1 threshold of 0.01; Finnish popmax point estimates are not used.
gnomad_v2 gnomad_v4
BS2 Not assessed Not assessed: gnomAD reports 31 homozygotes, but does not establish healthy-adult status, age, phenotypic evaluation, or early full penetrance.
gnomad_v2 gnomad_v4
BS3 Not assessed Not assessed: no variant-specific validated functional assay showing no damaging effect on WFS1 protein function or splicing was identified.
PMID:26435059 PMID:34997062
BS4 Met Met, strong: p.Glu776Val did not segregate with hearing impairment in the studied families, although complete pedigree details require review.
PMID:24909696 PMID:34997062
BP1 Not met Not met: WFS1 has a substantial documented missense disease mechanism, including C-terminal missense variants, rather than primarily truncating disease causation.
PMID:28432734 PMID:31638168
BP2 Not assessed Not assessed: maternal inheritance alone does not show a pathogenic variant in trans for dominant disease or in cis in any inheritance pattern.
PMID:34997062 PMID:24909696
BP3 N/A Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
BP4 Not met Not met: REVEL 0.981 is above the generic BP4 supporting threshold of 0.29, so it does not indicate a tolerated missense change.
revel
BP5 Not assessed Not assessed: no exact-variant case with a demonstrated alternate molecular basis for the relevant disease was documented.
PMID:31638168 PMID:34997062
BP6 Not met Not met: no exact-variant ClinVar expert-panel benign or likely-benign classification exists, and the published benign interpretation is independently available.
clinvar PMID:34997062
BP7 N/A Not applicable: BP7 requires a synonymous variant, and this is a missense variant.
generic_acmg_combination_rules
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.